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We characterized the genome and proteins of the canine minute virus (the minute virus of canines (MVC)). The genome
sequence showed MVC to be an autonomous parvovirus encoding a large nonstructural protein 1 gene, a smaller
nonstructural protein, and overlapping VP1 and VP2 protein genes. The virus was most closely related to bovine parvovirus
(BPV), with which it was 43% identical at the DNA sequence level, while the NS1 and VP1 proteins were 33.6 and 41.4%
identical to those of BPV, respectively. Spliced messages of the NS1 gene transcripts were detected by RT-PCR. VP1 and VP2d versioIntroduction. The canine minute virus, also known as
the minute virus of canines (MVC), was first described as
an isolate from a healthy dog in the U.S.A. (1). That virus
was grown in the Walter Reed canine (WRC) cell line and
had the properties of a parvovirus, including small size
(20–21 nm diameter), and the presence of virions in
infected cell nuclei (1–3). The MVC appeared antigeni-
cally and genetically distinct from the canine parvovirus
type-2 (CPV) based on antibody cross reactivity and
restriction enzyme analysis of the viral DNA (3), but its
genomic structure and relationship to other parvoviruses
has not been described. The distribution of MVC and its
association with canine diseases are also not well un-
derstood. Serological testing suggests that MVC is wide-
spread in dogs in the U.S.A., with over 50% positive
samples in the studies reported (1, 4). Although it is likely
that most infections with MVC are subclinical, diseases
associated with virus infection include fetal infections
leading to reproductive failure and neonatal respiratory
disease (2, 5, 6). The virus may also be associated with
some cases of enteritis in puppies or older dogs (1).
However, MVC is highly restricted in its tissue culture
replication; there are few sensitive diagnostic tests
widely available, and the true incidence of the virus
infection or its associated diseases are therefore not
1 Present address: Department of Cell Biology, Harvard Medical
School, Boston, MA 02115.219known. Parvoviruses are widespread pathogens of ver-
tebrate and invertebrate animals and are the cause of
many different diseases. They replicate through a linear
DNA replicative form (RF) and encapsidate a single-
stranded DNA genome of either a single polarity, or from
either DNA strand. Parvovirus capsids are assembled
from between two and four overlapping capsid proteins
that are generated by alternative splicing of one or two
viral mRNAs, or by use of alternative start codons in one
message (7).
Results. DNA sequence and analysis. The almost com-
plete sequence of the genome of MVC was obtained
from plasmid clones or directly from viral RF DNA and
that covered 5097 bases (Fig. 1; GenBank Accession No.
AF495467). We did not obtain the sequences of the very
3 and 5 ends of the genome, but by restriction analysis
of the RF DNA with XhoI (nt 470 in the sequence deter-
mined) and BsaMI (nt 5014 in the sequence determined),
we determined that the sequence obtained extended to
within 140 bases of the extended 3 end and 150 bases
of the extended 5 end, suggesting a total genomic
length of about 5390 bases. Electrophoretic analysis of
the RF DNA digested with XhoI and BsaMI showed that
the turn-around and extended forms of the 3 end dif-
fered in length by about 80 bases, and those of the 5
end differed in length by about 75 bases, indicating that
those palindromes contained about 160 and 150 bases,
respectively (results not shown).proteins were detected in purified capsids, as were modifie
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Comparing the MVC sequence with those of other
parvoviruses showed that the most closely related virus
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was the bovine parvovirus (BPV), with which it shared
43% DNA sequence identity. When a conserved region
within the translated sequence of the NS1 gene was
compared to the equivalent sequence from other parvo-
viruses, MVC was again closely related to BPV, and the
next closest relatives were the erythroviruses (human
B19 and simian parvoviruses) (Fig. 2). MVC was quite
distinct from canine parvovirus and feline panleukopenia
virus and the other viruses in the rodent virus-related
clade.
Large open reading frames (ORF) within the left and
right halves of the genome encoded proteins homolo-
gous to the NS1 and the VP1 and VP2 proteins, respec-
tively, of other parvoviruses, while a shorter ORF in the
middle of the genome overlapped with the sequence of
the NS1 protein, and that was similar to the predicted
NP-1 protein of BPV (Figs. 1 and 3) (8). The NS1 se-
quence likely initiated at a methionine codon at nt 429 in
the sequence and encoded a 717 residue protein with a
predicted molecular weight of 81.9 kDa, which shared
32.6% identity with the NS protein of BPV (Fig. 3A). The
right-hand ORF encoded VP1 and VP2 proteins of 78.9
and 63.9 kDa, respectively, which initiated at methionine
codons in the same reading frame, at nts 2933 and 3329
in the sequence (Fig. 3B). The 21.7-kDa protein encoded
by a third ORF was 39% identical to the NP-1 protein
predicted from the BPV sequence (Fig. 3C) (8). The first
188 nts of the NP1 ORF overlapped with the C-terminal
sequence of NS1.
Analysis of mRNAs by RT-PCR. We used RT-PCR to
isolate spliced mRNA products from MVC-infected cells
and then cloned the products and examined their se-
quences. Two different pairs of PCR primers were used
which would flank the introns described for many parvo-
viruses (Fig. 4). For the RT-PCR spanning the region
around the beginning of the VP1 ORF between nts 2601
and 3346 (Fig. 4, primer pair 2 and 3), the only product
detected was the intact 745-bp sequence, and no clones
were identified that would represent splices of these
sequences. For the RT-PCR spanning the 368- to 3346-nt
region of the genome (primer pair 1 and 3 in Fig. 4), the
predicted full-sized 2978-nt product was detected, as
well as products that appeared to be about 1100 nts and
smaller than 400 nts (Fig. 4). Clones isolated from the
middle-sized product had two splices that fused two
sequences within NS1 and part of the NP1 ORF. Smaller
products showed at least two sequences—in one 26
residues from the N-terminus of NS1 were fused to the
VP1 ORF, while the other fused the NS1 ORF to an
alternative ORF overlapping that of NP1. Whether the
NS1–VP1 fusion is formed in any quantity was not deter-
mined, but it is possible that those represent the origin of
the alternative forms of VP1 recovered from the viral
capsids (Fig. 5).
Protein Analysis. Purified MVC capsids contained a
number of protein forms, with a minor and major form
representing the VP1 and VP2 proteins (Fig. 5). The major
form of VP1 had an estimated size of 81 kDa, while the
VP2 forms were 67 and 63 kDa. VP3 (61 kDa) was
present in the full virus capsids, likely resulting from
cleavage of VP2 at arginine 19 in the VP2 sequence,
similar to that reported for MVM and CPV (9). Western
blotting of the proteins from MVC-infected cells using a
FIG. 2. A phylogeny showing the relationship of MVC to other mem-
bers of the family Parvovirinae, including Aleutian mink disease virus
(ADV), canine parvovirus (CPV), hamster parvovirus (hamster), LuIII,
mouse parvovirus (MPV), minute virus of mice (MVM), porcine parvo-
virus (PPV), BPV, MVC, human parvovirus B19 (B19), simian parvovirus
(SPV), chipmunk parvovirus (chipmunk), barbarie duck parvovirus (bar-
barie), goose parvovirus (GPV), and Muscovy duck parvovovirus (Mus-
covy). The tree was rooted using adenoassociated virus (AAV) as an
outgroup. A conserved sequence of 149 residues of the MVC NS1 was
aligned with the sequences of the other viruses indicated and the most
parsimonious phylogeny determined using the program PAUP 3.1.1. The
single tree determined is shown; the numbers shown indicate the
number of residues on each branch.
FIG. 1. (A) Cloning and sequencing the MVC genome. The central
portions of the genome were cloned into plasmids from the RF DNA or
from PCR products, while the 3 and 5 terminal sequences were
determined directly from the viral RF DNA. The sequence has been
deposited in GenBank (AF495467). (B) ORFs within the MVC sequence
shown as arrows. Labels indicate the ORFs homologous with NS1, NP1,
or VP1 and VP2 genes of the BPV.
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postinfection dog serum showed the VP2 protein, as well
as a protein band of about 80 kDa which could represent
the VP1 and NS1 proteins, which are close to this size
and would likely be recognized by the postinfection se-
rum (Fig. 5B).
FIG. 3. Alignments of the MVC protein sequences (top) with those of
BPV (bottom). (A) The NS1 ORF. Within the conserved central region of
the protein, the nucleotide-binding site required for DNA nicking iden-
tified in the MVM NS1 sequence is marked by the overlining. Con-
served residues that in MVM have been associated with nucleotide
binding or ATPase activity are indicated by circles and squares, re-
spectively. (B) The VP1/VP2 ORF. The conserved phospholipase A2-
specific residues in that sequence are indicated. Closed circles indi-
cate the active site motif (HDXXY) and the closed squares indicate the
Ca2 binding loop residues (YXGXG). The arrow indicates the predicted
start of the VP2 sequence. (C) The NP-1 ORF.
FIG. 4. The RT-PCR analysis of viral mRNA transcripts. (A) The
RT-PCR reactions performed are diagrammed, showing the three prim-
ers that were used to amplify the messages. Numbers indicate the
nucleotide in the genome complementary to the 3 end of each primer.
(B) The RT-PCR products detected in an agarose gel. Size of the
molecular weight standards in base pairs. (C) Spliced forms identified
in the PCR reactions, as determined from products cloned into plas-
mids and sequenced. The nucleotides at the junctions of the different
products are given.
FIG. 5. (A) Proteins of purified full and empty MVC particles detected
by Coomassie blue staining, compared to those of CPV full and empty
capsids. Size standards are shown in kDa. (B) Proteins from infected or
uninfected WR cells electrophoresed on a 10% acrylamide gel, trans-
ferred to a nitrocellulose membrane, and then probed with antibodies
from an SPF dog that had been infected with MVC.
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Discussion. The MVC has been associated with sev-
eral different diseases of fetal and neonatal puppies, and
by serological testing the virus appears to be wide-
spread in dogs, most likely causing subclinical infections
in many infected animals (1–6, 10). Here we show that
MVC is a distinct member of the Parvoviridae which is
most closely related to the bovine parvovirus, although it
shares only 43% identity in DNA sequence with that
virus. MVC was only distantly related to the well-charac-
terized CPV, as has been suggested by serological test-
ing and by restriction enzyme analysis of the viral DNA
(3).
The genetic structure of MVC was typical of a parvo-
virus, with large ORFs encoding the NS1, VP1, and VP2
proteins, along with a small ORF that partially overlapped
with the NS1 gene that was equivalent to the NP1 protein
of BPV (8, 11). The function of the NP1 protein is un-
known, and there is no obvious homology with any pro-
tein in the data bases. The NS1 protein sequence had a
conserved core that contained the sequences identified
as being involved in the nucleotide binding and DNA-
nicking activities of the protein (12, 13) (Fig. 3A). Se-
quences identified in the MVM NS1 as a metal coordi-
nation site (histidines 127 and 129), and to be part of the
active site (tyrosine 210), could not be clearly identified in
the NS1 of MVC or BPV. Conserved sequences that are
associated with the active site of a phospholipase A2
activity of the VP1 unique region of several parvoviruses
were present in the MVC and BPV sequences, suggest-
ing that that was a highly conserved function of the
protein (Fig. 3B) (14).
The mRNA transcripts identified by RT-PCR between
primer sites around nts 390 or 2618 and 3325 showed a
variety of possible mRNA forms producing a variety of
proteins (Fig. 4). We cannot define the significance of
those spliced products, but they appear similar to those
described for the Aleutian mink disease virus and the
human parvovirus B19, where a variety of spliced prod-
ucts have been reported, but for most of which the
functions have not been defined (15–17). The two capsid
proteins appear similar to the VP1 and VP2 proteins of
the other parvoviruses, but no evidence was found of a
spliced product within the 2618- to 3325-nt region, and
the two proteins are likely encoded by a single message
with translation initiating at two ATG codons to give VP1
and VP2.
The evolution and relationships of the parvoviruses is
only partially understood (18, 19). Among the viruses of
vertebrates there appear to be at least three distinct
clades, which include adenoassociated viruses which
are more closely related to the avian-derived viruses, the
rodent virus-related viruses which include canine parvo-
virus and minute virus of mice, and the erythroviruses
which include B19 and similar viruses from primates, as
well as the more distantly related BPV which is now
grouped with MVC. However, MVC is still only distantly
related to the other viruses, indicating that it diverged in
the distant past.
Materials and Methods. Virus growth, capsid, and DNA
purification. The GA3 isolate of MVC (5) was grown in
thinly seeded Walter Reed canine cells (1). Replicative
form DNA was harvested from infected cells 2 days after
virus inoculation by modification of the method of Hirt
(20). The cells were lysed into 10 mM Tris–HCl (pH 7.4) 10
mM EDTA, 0.6% SDS; then 20 mg/ml of Pronase was
added and incubated for 2 h at 37°C. The lysate was
made up to 1 M NaCl, incubated on ice, and then cen-
trifuged at 80,000 g for 1 h. The supernatant was col-
lected, ethanol precipitated, made up into 50 mM Tris–
HCl (pH 7.5), 5 mM EDTA, and extracted with phenol and
then with chloroform. The RF DNA was purified from a 1%
agarose gel by spin column extraction.
To prepare virus for protein analysis, WRC cells were
inoculated with virus for 1 h at 37°C. After 4 days of
incubation, the cells were frozen and thawed twice. Cap-
sids were pelleted from the culture supernatant at 80,000
g for 3 h; the pellet was sonicated for 2 min, and then the
virus was banded in 10 to 40% sucrose gradients at
90,000 g for 6 h. Proteins in each gradient fraction were
electrophoresed in 10% SDS–polyacrylamide gels (21),
and the gels stained with Coomassie blue. Purified full
and empty capsids of canine parvovirus were included
for comparison. To examine the proteins in infected cells,
lysates of infected cells were electrophoresed in 10%
PAGE and then transferred to nitrocellulose membranes
and incubated with a postinfection dog serum. The blot
was incubated with goat anti-dog IgG conjugated with
horseradish peroxidase and then with Super-Signal sub-
strate (Pierce Chemical, Rockford, IL).
DNA Cloning and Sequencing. The strategy for cloning
and sequencing the viral genome is diagrammed in Fig.
1A. The RF DNA was digested with BamHI, EcoRI,
HindIII, or TaqI (3). DNA fragments were cloned into the
vector pGEM3Z (Promega, Madison, WI); sequences
were obtained with SP6 and T7 primers from the flanking
regions in the plasmids. Sequences were determined in
both orientations by automated sequencing with a vari-
ety of specific primers. A 1177-base region between the
HindIII site and a TaqI fragment was amplified from virus
DNA by PCR and cloned into the vector pGEM-T easy
(Promega), and three clones sequenced. To obtain se-
quences near the ends of the genome, purified viral RF
DNA (100 ng/l) recovered from infected cells was se-
quenced directly using specific primers annealing near
the ends of the sequences obtained from the cloned
DNA fragments, and sequences were also obtained di-
rectly from the RF DNA using reverse primers. The viral
genomic sequence was analyzed using the program
DNAStar. The translated open ORFs identified were
aligned with those of BPV, the most closely related se-
quence in GenBank.
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A highly conserved region of the NS1 gene (residues
332 to 481, equivalent to residues 412 and 562 of the
MVMp NS1 sequence) was aligned with the homologous
regions of other parvoviruses, and the phylogenetic re-
lationships were determined using the branch-and-
bound algorithm of the program PAUP 3.1.1.
RT-PCR and Sequencing of Viral Messages. RT-PCR
was used to examine for possible spliced products in the
viral RNAs. Primers prepared were from positions 368–
389 (5-GCAAAGAGCACTGGGCGGTATT-3), 2601–2618
(5-ACCTCTTCCTGCGTTCTG-3), and 3346–3325 (5-
AGTTTCCTGCGGTTCCATCCTA-3). RNA was isolated
using the RNAgents kit (Promega); then cDNA was pre-
pared from the total RNA using specific primers and the
Access RT-PCR kit (Promega). The PCR products were
run on a 1% agarose gel. To determine the origins of
specific products, the amplified DNAs in different bands
were isolated from the agarose gel and ligated into the
pGEM-T Easy plasmid. Then plasmids were sequenced
using the T7 and SP6 primers in the vector.
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